Cheng‐Ta Yang

9.9k citations
283 papers · 6.4k · 2 hit papers · h-index 42

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Respiratory Support and Mechanisms
  • Oncology top 1%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Treatments and Mutations 108
    • Lung Cancer Diagnosis and Treatment 44
    • Respiratory Support and Mechanisms 28
    • Gastric Cancer Management and Outcomes 25
    • Colorectal Cancer Treatments and Studies 46
    • Lung Cancer Research Studies 39
    • Cancer Immunotherapy and Biomarkers 18

Cheng‐Ta Yang

270 papers receiving 6.3k citations

Hit Papers

Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography 2023 · 114 citations
1140+1+2Years since publication50100150200

Peers

Cheng‐Ta Yang
Comparison fields: 5 of 152
  • Pulmonary and Respiratory Medicine 2.5k
  • Oncology 2.0k
  • Cancer Research 666
  • Nephrology 234
  • Endocrine and Autonomic Systems 194
Replace Peter Schemmer with:
Peter Schemmer Germany
Hiroki Takahashi Japan
Aliya N. Husain United States
Michael Gregor Germany
Masahiko Yano Japan
Joanne Verheij Netherlands
Tsutomu Masaki Japan
Efstratios Patsouris Greece
Alfredo Pontecorvi Italy
Li Chen China
Cheng‐Ta Yang relative to Peter Schemmer Germany Peter Schemmer's profile →
Citations per field
00.5×1.5×2.0×
Peter Schemmer · 1×
Citations per year

Countries citing papers authored by Cheng‐Ta Yang

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Ta Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Ta Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Ta Yang more than expected).

Fields of papers citing papers by Cheng‐Ta Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Ta Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Ta Yang. The network helps show where Cheng‐Ta Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Cheng‐Ta Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheng‐Ta Yang Line = papers co-authored together Cheng‐Ta Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 283 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study
Hit paper breakdown →
2022238
2 2008234
3 2019170
4 2006156
5 2019148
6 2005144
7 2021135
8
Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography
Hit paper breakdown →
2023114
9 2008110
10 200096
11 201696
12
ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
200094
13 201184
14 202083
15 201782
16 201881
17 201580
18 200777
19 201577
20 201477

About Cheng‐Ta Yang

Cheng‐Ta Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Physiology, having authored 283 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (108 papers), Colorectal Cancer Treatments and Studies (46 papers), Lung Cancer Diagnosis and Treatment (44 papers), Lung Cancer Research Studies (39 papers), Respiratory Support and Mechanisms (28 papers), Gastric Cancer Management and Outcomes (25 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Obstructive Sleep Apnea Research (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.5k citations), Oncology (2.0k citations), Cancer Research (666 citations), Nephrology (234 citations) and Endocrine and Autonomic Systems (194 citations). Cheng‐Ta Yang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Gur P. Kaushal, David M. Jablons, Varsha Kaushal, Liang You, Ping‐Chih Hsu, Sudhir V. Shah, Kuo‐Chin Kao, Chung-Chi Huang, Li‐Fu Li and Christian Herzog. Their work appears in journals such as Annals of Oncology, Cancers, PLoS ONE, Journal of Clinical Oncology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact